NEW YORK HEALTH FORUM & NEW YORK PHARMA FORUM
Co-Hosting “Furthering Global Biopharma: Opportunities for Development with East Asia”

FORUM_Title2

November 12 (Thursday), 2015
1:00 ~ 6:00pm
Nippon club: 145 W 57th St, New York, NY 10019 [Show on Map]

NETWORK RECEPTION (12:30~1:00pm)

Opening Statement (1:00~1:10pm)
“Opportunities for Collaboration with Japan’s Public Sector and Academia”

DoHyun Cho, PhD, Chairman, New York Health Forum
(CEO & President, W Medical Strategy Group)
Tom Heffner, PhD, President, New York Pharma Forum
(Executive Director, Worldwide Business Development, Pfizer)

FORUM

Session1: “Opportunities for Collaboration with Japan’s Public Sector and Academia” (1:15~2:30pm)

Panels

Hideki Mitani, Senior Advisor to Director General (Institute of Industrial Science, Senior Advisor to Dean, The institute of Medical Science, The University of Tokyo)
Hiroyuki Kawabata, Director (Health and Welfare Department, JETRO New York)
Kenjiro Watanabe, Director (Business Development, JETRO New York)

Session2: “Designing and Conducting Clinical Trials in Asia” (2:00~2:50pm)

Panels

James M Pusey, MD, MBA (SVP Clinical Operations, Medpace Inc.)
Networking Break (2:50~3:10pm)

Session3: “New Drug Discovery and Development in Korea: A Case Study” (3:10~3:50pm)

Panels

Saeho Chong, PhD, Sr VP Business Development (Enzychem Lifesciences USA Corporation)
Session4: “Opportunities and Deal Making with Asian Biopharma” (3:50~4:50pm)
Moderator: Kimberly Ha, Senior Director, FTI Consulting 

Panels

Kathryn Gregory, MBA (Exec Director, Licensing and Business Development, Purdue Pharma L.P)
Daniel Chain, PhD (President & CEO, CereSpir, Inc.)
Shoshana Shendelman, PhD (Managing Director, Clearpoint Strategy Group, LLC)
Tony Chen, CEO (PrimeVax Immuno-Oncology, Inc.)

forum_4th_01

NETWORK RECEPTION (5:00~6:00pm)